Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis.
Authors: Song D; Department of Neurology, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China., Hou S; Department of Gastrointestinal Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, China., Ma N; Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China., Yan B; Department of Gastrointestinal Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, China., Gao J; Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Source: Frontiers in immunology [Front Immunol] 2024 Nov 01; Vol. 15, pp. 1485303. Date of Electronic Publication: 2024 Nov 01 (Print Publication: 2024).
Publication Type: Meta-Analysis; Systematic Review; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1485303